PirainoB., BernardiniJ., SorkinM.The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter in patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis1986; 8: 436–40.
2.
National Institutes of Health CAPD Registry, 1987.
3.
HolleyJ.L., BernardiniJ., PirainoB.Infecting organ isms in continuous ambulatory peritoneal dialysis patients on the y -setAm J Kidney Dis1994; 23: 569–73.
Perez-FontanM., Garcia-FalconT., RosalesM.Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long term
7.
BernardiniJ., PirainoB., HolleyJ., JohnstonJ.R., LutesR.A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.Am J Kidney Dis1996; 27(5): 695–700.
8.
ReadR.R., EberweinP., DasguptaM.Peritonitis in peritoneal dialysis: bacterial colonization by biofilm spread along the catheter surface.Kidney Int1989; 35(2): 614–21.
ZimmermanS.W., O'BrienM., WiedenhoeftF.A., JohnsonC.A.Staphylococcus aureus peritoneal catheter-related infections: a cause of catheter loss and peritonitis.Perit Dial Bull1988; 8: 191–4.
